Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function

Journal of Immunology

Volumn 184, Issue 11, 2010, Pages 6396-6406

  Sabeh, Farideh ^a   Fox, David ^a   Weiss, Stephen J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; MATRIX METALLOPROTEINASE 14; MMP14 PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VIVO STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIOCYTE; CELL CULTURE; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SYNOVIUM; WESTERN BLOTTING;

ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELLS, CULTURED; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MATRIX METALLOPROTEINASE 14; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SYNOVIAL MEMBRANE;

EID: 77953399151     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904068     Document Type: Article

References (70)

1. Noss, E. H., and M. B. Brenner. 2008. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol. Rev. 223: 252-270.
2. Müller-Ladner, U., T. Pap, R. E. Gay, M. Neidhart, and S. Gay. 2005. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 1: 102-110.
3. Burrage, P. S., K. S. Mix, and C. E. Brinckerhoff. 2006. Matrix metalloproteinases: role in arthritis. Front. Biosci. 11: 529-543.
4. Lainer-Carr, D., and E. Brahn. 2007. Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat. Clin. Pract. Rheumatol. 3: 434-442.
5. Puente, X. S., L. M. Sánchez, C. M. Overall, and C. López-Otín. 2003. Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 4: 544-558.
6. Li, Z., Y. Yasuda, W. Li, M. Bogyo, N. Katz, R. E. Gordon, G. B. Fields, and D. Brömme. 2004. Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J. Biol. Chem. 279: 5470-5479.
7. Li, Z., W. S. Hou, C. R. Escalante-Torres, B. D. Gelb, and D. Bromme. 2002. Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate. J. Biol. Chem. 277: 28669-28676.
8. Ohuchi, E., K. Imai, Y. Fujii, H. Sato, M. Seiki, and Y. Okada. 1997. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272: 2446-2451.
9. Sabeh, F., X. Y. Li, T. L. Saunders, R. G. Rowe, and S. J. Weiss. 2009. Secreted versus membrane-anchored collagenases: relative roles in fibroblast-dependent collagenolysis and invasion. J. Biol. Chem. 284: 23001-23011.
10. d'Ortho, M. P., H. Will, S. Atkinson, G. Butler, A. Messent, J. Gavrilovic, B. Smith, R. Timpl, L. Zardi, and G. Murphy. 1997. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250: 751-757.
11. Hotary, K., E. Allen, A. Punturieri, I. Yana, and S. J. Weiss. 2000. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149: 1309-1323.
12. Konttinen, Y. T., M. Ainola, H. Valleala, J. Ma, H. Ida, J. Mandelin, R. W. Kinne, S. Santavirta, T. Sorsa, C. López-Otín, and M. Takagi. 1999. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann. Rheum. Dis. 58: 691-697.
13. Yamanaka, H., K. Makino, M. Takizawa, H. Nakamura, N. Fujimoto, H. Moriya, R. Nemori, H. Sato, M. Seiki, and Y. Okada. 2000. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium. Lab. Invest. 80: 677-687.
14. Yoshihara, Y., H. Nakamura, K. Obata, H. Yamada, T. Hayakawa, K. Fujikawa, and Y. Okada. 2000. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59: 455-461.
15. Pap, T., Y. Shigeyama, S. Kuchen, J. K. Fernihough, B. Simmen, R. E. Gay, M. Billingham, and S. Gay. 2000. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum. 43: 1226-1232. (Pubitemid 30416307)
16. Honda, S., K. Migita, Y. Hirai, T. Origuchi, S. Yamasaki, M. Kamachi, K. Shibatomi, T. Fukuda, M. Kita, A. Hida, et al. 2001. Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cells. Clin. Exp. Immunol. 126: 131-136.
17. Hou, W. S., Z. Li, R. E. Gordon, K. Chan, M. J. Klein, R. Levy, M. Keysser, G. Keyszer, and D. Brömme. 2001. Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation. Am. J. Pathol. 159: 2167-2177.
18. Hou, W. S., W. Li, G. Keyszer, E. Weber, R. Levy, M. J. Klein, E. M. Gravallese, S. R. Goldring, and D. Brömme. 2002. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum. 46: 663-674.
19. Westhoff, C. S., D. Freudiger, P. Petrow, C. Seyfert, J. Zacher, J. Kriegsmann, T. Pap, S. Gay, P. Stiehl, E. Gromnica-Ihle, and D. Wernicke. 1999. Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. Arthritis Rheum. 42: 1517-1527.
20. Chabaud, M., P. Garnero, J. M. Dayer, P. A. Guerne, F. Fossiez, and P. Miossec. 2000. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12: 1092-1099. (Pubitemid 30479493)
21. Konttinen, Y. T., J. Mandelin, T. F. Li, J. Salo, J. Lassus, M. Liljeström, M. Hukkanen, M. Takagi, I. Virtanen, and S. Santavirta. 2002. Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. Arthritis Rheum. 46: 953-960.
22. Tolboom, T. C., E. Pieterman, W. H. van der Laan, R. E. Toes, A. L. Huidekoper, R. G. Nelissen, F. C. Breedveld, and T. W. Huizinga. 2002. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann. Rheum. Dis. 61: 975-980.
23. Sen, M., J. Reifert, K. Lauterbach, V. Wolf, J. S. Rubin, M. Corr, and D. A. Carson. 2002. Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum. 46: 2867-2877.
24. García-Vicuña, R., M. V. Gómez-Gaviro, M. J. Domínguez-Luis, M. K. Pec, I. González-Alvaro, J. M. Alvaro-Gracia, and F. Díaz-González. 2004. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum. 50: 3866-3877.
25. Pap, T., M. Nawrath, J. Heinrich, M. Bosse, A. Baier, K. M. Hummel, P. Petrow, S. Kuchen, B. A. Michel, R. E. Gay, et al. 2004. Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum. 50: 2794-2802.
26. Distler, J. H., A. Jüngel, L. C. Huber, C. A. Seemayer, C. F. Reich, III, R. E. Gay, B. A. Michel, A. Fontana, S. Gay, D. S. Pisetsky, and O. Distler. 2005. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc. Natl. Acad. Sci. USA 102: 2892-2897.
27. Tomita, T., T. Nakase, M. Kaneko, K. Shi, K. Takahi, T. Ochi, and H. Yoshikawa. 2002. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum. 46: 373-378.
28. Lazarus, G. S., J. L. Decker, C. H. Oliver, J. R. N. Daniels, C. V. Multz, and H. N. I. Fullmer. 1968. Collagenolytic activity of synovium in rheumatoid arthritis. N. Engl. J. Med. 279: 914-919.
29. Harris, E. D., Jr., D. R. DiBona, and S. M. Krane. 1969. Collagenases in human synovial fluid. J. Clin. Invest. 48: 2104-2113.
30. Werb, Z., C. L. Mainardi, C. A. Vater, and E. D. Harris, Jr. 1977. Endogenous activiation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N. Engl. J. Med. 296: 1017-1023.
31. Tran, C. N., M. J. Davis, L. A. Tesmer, J. L. Endres, C. D. Motyl, C. Smuda, E. C. Somers, K. C. Chung, A. G. Urquhart, S. K. Lundy, et al. 2007. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes. Arthritis Rheum. 56: 1497-1506.
32. Pei, D., and S. J. Weiss. 1995. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375: 244-247.
33. Netzel-Arnett, S., D. J. Mitola, S. S. Yamada, K. Chrysovergis, K. Holmbeck, H. Birkedal-Hansen, and T. H. Bugge. 2002. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity. J. Biol. Chem. 277: 45154-45161.
34. Sabeh, F., I. Ota, K. Holmbeck, H. Birkedal-Hansen, P. Soloway, M. Balbin, C. Lopez-Otin, S. Shapiro, M. Inada, S. Krane, et al. 2004. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol. 167: 769-781.
35. Creemers, L. B., D. C. Jansen, A. van Veen-Reurings, T. van den Bos, and V. Everts. 1997. Microassay for the assessment of low levels of hydroxyproline. Biotechniques 22: 656-658.
36. Hotary, K. B., I. Yana, F. Sabeh, X. Y. Li, K. Holmbeck, H. Birkedal-Hansen, E. D. Allen, N. Hiraoka, and S. J. Weiss. 2002. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J. Exp. Med. 195: 295-308.
37. Pei, D., and S. J. Weiss. 1996. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271: 9135-9140.
38. Yana, I., and S. J. Weiss. 2000. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol. Biol. Cell 11: 2387-2401.
39. Hotary, K., X. Y. Li, E. Allen, S. L. Stevens, and S. J. Weiss. 2006. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev. 20: 2673-2686.
40. Ota, I., X. Y. Li, Y. Hu, and S. J. Weiss. 2009. Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. Proc. Natl. Acad. Sci. USA 106: 20318-20323.
41. Hollander, A. P., I. Pidoux, A. Reiner, C. Rorabeck, R. Bourne, and A. R. Poole. 1995. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J. Clin. Invest. 96: 2859-2869.
42. Milner, J. M., A. Patel, and A. D. Rowan. 2008. Emerging roles of serine proteinases in tissue turnover in arthritis. Arthritis Rheum. 58: 3644-3656.
43. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320: 365-376.
44. Hiraoka, N., E. Allen, I. J. Apel, M. R. Gyetko, and S. J. Weiss. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95: 365-377.
45. Owen, C. A., Z. Hu, C. Lopez-Otin, and S. D. Shapiro. 2004. Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J. Immunol. 172: 7791-7803.
46. Sabeh, F., R. Shimizu-Hirota, and S. J. Weiss. 2009. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J. Cell Biol. 185: 11-19.
47. Coleman, C. M. 2008. Chicken embryo as a model for regenerative medicine. Birth Defects Res. C Embryo Today 84: 245-256.
48. Ribatti, D., A. Vacca, F. P. Cantatore, R. Ria, V. Benagiano, L. Roncali, and F. Dammacco. 2000. An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis. Inflamm. Res. 49: 418-423.
49. Bromley, M., and D. E. Woolley. 1984. Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion. Arthritis Rheum. 27: 857-863.
50. Rowe, R. G., and S. J. Weiss. 2009. Navigating ECM barriers at the invasive front: the cancer cell-stroma interface. Annu. Rev. Cell Dev. Biol. 25: 567-595.
51. Holmbeck, K., and L. Szabova. 2006. Aspects of extracellular matrix remodeling in development and disease. Birth Defects Res. C Embryo Today 78: 11-23.
52. Fitch, J. M., J. M. Kidder, and T. F. Linsenmayer. 2005. Cellular invasion of the chicken corneal stroma during development: regulation by multiple matrix metalloproteases and the lens. Dev. Dyn. 232: 106-118.
53. Miller, M. C., H. B. Manning, A. Jain, L. Troeberg, J. Dudhia, D. Essex, A. Sandison, M. Seiki, J. Nanchahal, H. Nagase, and Y. Itoh. 2009. Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis. Arthritis Rheum. 60: 686-697.
54. Cho, J. A., P. Osenkowski, H. Zhao, S. Kim, M. Toth, K. Cole, A. Aboukameel, A. Saliganan, L. Schuger, R. D. Bonfil, and R. Fridman. 2008. The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP. J. Biol. Chem. 283: 17391-17405.
55. Tomari, T., N. Koshikawa, T. Uematsu, T. Shinkawa, D. Hoshino, N. Egawa, T. Isobe, and M. Seiki. 2009. High throughput analysis of proteins associating with a proinvasive MT1-MMP in human malignant melanoma A375 cells. Cancer Sci. 100: 1284-1290.
56. Rutkauskaite, E., D. Volkmer, Y. Shigeyama, J. Schedel, G. Pap, U. Müller-Ladner, I. Meinecke, D. Alexander, R. E. Gay, S. Drynda, et al. 2005. Retroviral gene transfer of an antisense construct against membrane type 1 matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 52: 2010-2014.
57. Onguchi, T., K. Y. Han, J.-H. Chang, and D. T. Azar. 2009. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization. Am. J. Pathol. 174: 1564-1571.
58. Sounni, N. E., C. Roghi, V. Chabottaux, M. Janssen, C. Munaut, E. Maquoi, B. G. Galvez, C. Gilles, F. Frankenne, G. Murphy, et al. 2004. Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. J. Biol. Chem. 279: 13564-13574.
59. Deryugina, E. I., L. Soroceanu, and A. Y. Strongin. 2002. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res. 62: 580-588.
60. Sounni, N. E., L. Devy, A. Hajitou, F. Frankenne, C. Munaut, C. Gilles, C. Deroanne, E. W. Thompson, J. M. Foidart, and A. Noel. 2002. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 16: 555-564.
61. Basile, J. R., K. Holmbeck, T. H. Bugge, and J. S. Gutkind. 2007. MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J. Biol. Chem. 282: 6899-6905.
62. Weathington, N. M., A. H. van Houwelingen, B. D. Noerager, P. L. Jackson, A. D. Kraneveld, F. S. Galin, G. Folkerts, F. P. Nijkamp, and J. E. Blalock. 2006. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat. Med. 12: 317-323.
63. Van den Steen, P. E., P. Proost, D. D. Brand, A. H. Kang, J. Van Damme, and G. Opdenakker. 2004. Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B. Biochemistry 43: 10809-10816.
64. Akhavani, M. A., L. Madden, I. Buysschaert, B. Sivakumar, N. Kang, and E. M. Paleolog. 2009. Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis. Arthritis Res. Ther. 11: R64.
65. Sivakumar, B., M. A. Akhavani, C. P. Winlove, P. C. Taylor, E. M. Paleolog, and N. Kang. 2008. Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. J. Hand Surg. Am. 33: 49-58.
66. Petrella, B. L., J. Lohi, and C. E. Brinckerhoff. 2005. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma. Oncogene 24: 1043-1052.
67. Yook, J. I., X. Y. Li, I. Ota, C. Hu, H. S. Kim, N. H. Kim, S. Y. Cha, J. K. Ryu, Y. J. Choi, J. Kim, et al. 2006. AWnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 8: 1398-1406.
68. Schett, G., J. Zwerina, and J. P. David. 2008. The role of Wnt proteins in arthritis. Nat. Clin. Pract. Rheumatol. 4: 473-480.
69. Karouzakis, E., R. E. Gay, S. Gay, and M. Neidhart. 2009. Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat. Rev. Rheumatol. 5: 266-272.
70. Moss, N. M., M. V. Barbolina, Y. Liu, L. Sun, H. G. Munshi, and M. S. Stack. 2009. Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination. Cancer Res. 69: 7121-7129.